Heart Failure and stem cell therapy
Breathless on the stairs, swollen ankles, tired by noon: heart failure narrows daily life even with good medical care. Many people and their families want to know what else may support the heart.
Medically reviewed by:Javier E. Garrido L.MD, MSc
On this page
What is heart failure?
Heart failure means the heart muscle pumps less blood than the body needs. The heart keeps beating, and over time fluid can build up in the lungs, legs and abdomen. It most often follows a heart attack, coronary artery disease or long-standing high blood pressure, and can also come from diabetes, valve disease or inflammation of the heart muscle. Doctors describe two main types: heart failure with reduced ejection fraction, where the heart muscle is weakened, and heart failure with preserved ejection fraction, where it is stiff. Ongoing inflammation is part of how heart failure progresses.

At Regeneration Clinic Panama, we take an individualized approach to your care. Our medical team will review your condition, medical history, and individual needs to help you understand your treatment options.
Book a ConsultationCommon signs and symptoms
Sudden severe shortness of breath, chest pain or fainting is an emergency: call 911.
- Shortness of breath with activity or when lying flat
- Fatigue and weakness
- Swelling in the legs, ankles, feet or abdomen
- Rapid weight gain from fluid
- Persistent cough or wheezing
- Reduced ability to exercise
- Waking at night short of breath
- Rapid or irregular heartbeat
How heart failure is usually treated
Heart failure is managed by a cardiologist, often with a dedicated heart failure team. Guideline-directed medicines include diuretics, ACE inhibitors, ARBs or ARNIs, beta blockers, aldosterone antagonists and SGLT2 inhibitors. Some people benefit from devices such as implantable defibrillators or cardiac resynchronization pacemakers, and in advanced cases ventricular assist devices or a heart transplant. Lower salt, daily weight checks and cardiac rehabilitation also matter. These treatments help people live longer and must continue. Many people still live with breathlessness and fatigue, and look for ways to support the heart muscle itself.

How stem cell therapy works for heart failure
In heart failure, ongoing inflammation and scarring keep weakening the heart muscle. Mesenchymal stem cells reduce inflammation, release factors that support heart muscle cells and small blood vessels, and help regulate the immune response. Heart failure is one of the most studied areas of mesenchymal stem cell research, including a randomized trial of intravenous umbilical cord mesenchymal stem cells. We use mesenchymal stem cells from the Wharton’s Jelly of donated umbilical cords as part of selected personalized protocols, added to your existing care. You keep working with your cardiologist and never stop your medication.
Every patient with heart failure has a different history and set of needs, so we start with a full evaluation. Your physician reviews your history, symptoms, previous treatments and test results before deciding whether a regenerative protocol is appropriate. When it is, cell therapy becomes one part of a personalized care plan.
Important: cellular therapy is an evolving area of medicine. Outcomes vary, and treatment decisions are made individually after a medical assessment.
What the research says
These studies were published by independent research teams. Their results are separate from our own patient outcomes.
- Source link
In the RIMECARD phase 1/2 randomized trial, 30 adults with stable heart failure with reduced ejection fraction, all on optimal medical treatment, received intravenous umbilical cord mesenchymal stem cells or placebo.
The infusions were well tolerated, and the mesenchymal stem cell group showed improved ejection fraction, symptom class and quality of life scores over 12 months.
- Source link
DREAM-HF, a randomized, double-blind trial of 565 adults with heart failure with reduced ejection fraction, tested bone marrow-derived mesenchymal precursor cells injected into the heart muscle.
Its main goal, fewer heart failure events, was not met; exploratory analyses showed fewer heart attacks and strokes, especially in people with high inflammation.
- Source link
In the MSC-HF randomized, double-blind trial of 60 adults with severe ischemic heart failure, their own bone marrow mesenchymal stem cells injected into the heart muscle improved heart volume and pumping measures at six months compared with placebo.
Symptoms and walking distance did not differ between groups.
Heart failure has some of the most developed mesenchymal stem cell research in cardiology, including randomized trials, though results are mixed and larger trials are still needed.
Who may consider this
A personalized evaluation may be right for you if you:
- Have heart failure diagnosed and managed by a cardiologist
- Take guideline-directed heart failure medicines and plan to continue them
- Still live with breathlessness, fatigue or limited activity
- Are medically stable, without a recent hospital admission for heart failure
- Share recent echocardiograms, lab results and cardiology records with our physicians
Our medical team decides suitability after reviewing each case.
What to expect
Before Treatment
Our team reviews your medical history and diagnostic information. We may recommend extra tests to understand your current health and whether you may be a candidate.
During Your Stay
If you are eligible, our medical team guides you through each stage of treatment and provides clinical support throughout.
After Treatment
We follow up at 1, 3, 6, 9 and 12 months after treatment and adjust your plan as needed.

Schedule a personalized consultation to discuss your medical history, treatment goals, and potential care options.
Book a ConsultationRelated articles
Real Patients. Real Results.
Patient stories share individual experiences. Results vary, and no outcome is promised.


- Takes less than 2 minutes
- No commitment
- Takes less than 2 minutes
- No commitment
Your questions
Read Full FAQAnswers about safety, cost and what to expect.
No. Never stop or change your heart failure medication on your own. These medicines protect your heart. You keep working with your cardiologist, and our physicians coordinate with them before anything is recommended.
No. Mesenchymal stem cell therapy is considered only as an addition to standard heart failure care. Your cardiologist remains in charge of your medicines, devices and monitoring.
Most mesenchymal stem cell research has studied heart failure with reduced ejection fraction. Evidence in heart failure with preserved ejection fraction is very limited, and our physicians will explain what applies to you.
No. Mesenchymal stem cell therapy is not FDA-approved for heart failure in the US. Several trials are ongoing, and results so far are mixed.
Mesenchymal stem cells are recognized for medical use in the European Union and Australia, with hundreds of clinical trials underway worldwide. In December 2024, the FDA approved the first mesenchymal stem cell product in the United States, for steroid-refractory acute graft-versus-host disease in children. For other conditions, mesenchymal stem cell therapy is not FDA-approved in the US.
Protocols start at $10,000 USD, and your exact cost depends on your protocol. Treatment is not covered by insurance. Results vary from patient to patient and no outcome is promised.

Still have a question?
Ask us directly. A patient advocate will reply personally.






